Physician profile
Laura N Sciaroni
NPI 1649236019
$1,795.84
in general payments reported to CMS, 2019-2025
11 companies · $21.54 in 2025
The $21.54 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2021: $96.85 · 2022: $1,469 · 2024: $22.65 · 2025: $21.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,283.30 | 2022-2025 | |
| Electronic Waveform Lab, INC. | $178.45 | 2022 | |
| Zimmer Biomet Holdings, INC. | $100.79 | 2019 | |
| Ermi LLC | $37.03 | 2019 | |
| Grt US Holding, INC. | $34.11 | 2022 | |
| Depuy Synthes Sales INC. | $32.48 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $31.63 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $31.56 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $23.99 | 2019 | |
| Bioventus LLC | $23.68 | 2021 | |
| Ibsa Pharma INC. | $18.82 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Sciaroni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.